Gene Query: C1GALT1C1

Dataset Description Geneva Score
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 28.38
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 20.9
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 18.29
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 15.79
Effect of Hotair overexpression in human breast cancer cell lines 15.63
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 14.79
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 14.27
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 13.83
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 13.44
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 12.97
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 12.68
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 12.23
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 12.08
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.71
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 11.6
Tracking of dCas9-methyltransferase footprints 10.25
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 10.13
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 10.1
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 10.1
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.02
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 9.99
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.39
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.39
Gene expression in PANC1 cells treated with Rakicidin 9.0
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 8.99
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 8.99
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.9
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.9
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.5
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.5
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 8.44
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 8.43
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 8.33
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.26
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 7.87
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 7.87
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 7.83
TCF7L1 knockdown in pancreatic cancer 7.8
Genome-wide analysis of the Integrator complex (HTS) 7.75
Genome-wide analysis of the Integrator complex 7.75
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.73
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.73
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.62
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 7.49
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 7.47
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 7.35
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 7.26
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 7.26
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.06
Effect of from Human Umbilical Vein Endothelial Cells 6.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 6.84
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 6.84
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 6.69
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 6.4
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 6.38
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 6.31
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 6.19
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 6.12
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.11
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.1
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.72
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.66
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.66
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.66
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 5.56
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.5
Regulation of protein translation during mitosis 5.46
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 5.41
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.27
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 5.27
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 5.27
GATA3-mediated chromatin reprogramming in breast cancer cells 5.25
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.24
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 5.24
RNA-seq of human fibroblasts after irradiation 5.22
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.18
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.07
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 5.06
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.0
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.97
Co-transcriptional loading of RNA export factors shapes the human transcriptome 4.96
RNAseq of HEK293 cells after Chtop knockdown 4.96
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.93
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.92
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.92
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 4.88
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.84
Non-coding regions are the main source of tumor-specific antigens 4.81
Non-coding regions are the main source of tumor-specific antigens [human] 4.81
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 4.79
Rorc disruption in human FG pancreatic cancer cells 4.78
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.78
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 4.76
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.7
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 4.67
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.53
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.49
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.47
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.37
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.35
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.35
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.34
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 4.32
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.23
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.22
LNCaP treated with iBET 4.22
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 4.17
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.17
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.16
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.15
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.15
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.15
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.12
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.11
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.03
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 3.99
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 3.99
Identification of renal resident macrophages across species [C1] 3.97
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 3.97
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.96
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 3.96
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 3.92
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.92
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.91
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.83
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.82
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.82
Transcriptional profiling of microglia; current state of the art and future perspectives 3.8
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.79
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.77
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.72
High-Throughput Kinetic Analysis of Fractional Killing 3.71
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 3.71
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 3.7
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.7
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.69
Single cell transcriptome of peritoneal cells 3.67
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 3.67
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 3.62
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 3.62
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.62
Differential gene expression of human melanoma cells [RNA-seq] 3.62
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.61
KSDM1b Role in Ewing Sarcoma 3.6
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.6
The role of FAM46C in myeloma cells [sequencing] 3.59
The role of FAM46C in myeloma cells 3.59
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.59
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.59
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.57
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 3.57
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 3.57
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.56
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.55
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.52
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.5
Mitochondrial dsRNA triggers antiviral signalling in humans 3.46
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.35
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.33
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 3.31
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.3
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.3
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.26
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.25
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.25
Regulation of Lipids is Central to Replicative Senescence 3.24
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.24
The evolution of N6-methyladenosine in primates 3.23
The human blood-nerve barrier transcriptome 3.23
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 3.21
Gene expression profiling of human and murine in vitro muscle differentiation 3.21
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.2
NKX2.2 3.18
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.18
Gene expression changes after LOC550643 silencing 3.16
Electronic cigarettes 3.16
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.13
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 3.13
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.09
Generation of trichogenic adipose-derived stem cells by expression of three factors 3.08
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.06
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.06
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.05
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.05
Altering cancer transcriptomes using epigenomic inhibitors 3.03
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.03
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.02
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.01
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.0
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.97
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.95
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.95
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.94
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.94
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.93
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 2.92
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.91
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.9
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.9
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 2.9
Effect of ILF3 on translation during homeostasis and the antiviral response 2.89
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.89
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.88
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.87
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.87
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 2.86
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 2.86
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 2.85
Lineage specific differentiation is influenced by state of human pluripotency 2.85
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 2.85
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.84
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.84
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.84
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.83
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 2.82
RNAseq of cell lines with knocked in ESR1 mutations 2.81
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 2.8
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.8
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 2.78
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.77
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.76
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.76
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 2.76
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.75
Single-Cell Genotyping of Transcriptomes 2.75
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.74
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 2.72
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 2.72
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.72
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.71
mRNA differential expression analysis in a human ex vivo model of chronic wounds 2.7
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.66
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.65
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 2.64
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 2.64
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 2.64
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 2.63
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.61
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.59
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.57
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 2.53
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.52
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.51
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 2.49
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 2.49
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.48
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.47
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.47
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 2.46
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.46
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.46
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.45
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.45
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.43
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.43
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.4
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.36
CHD1 regulates cell fate determination by activation of differentiation-induced genes 2.36
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 2.35
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.35
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.35
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 2.33
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.32
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.31
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.28
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.27
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.27
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.26
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.26
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.26
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.25
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.25
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.24
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.24
T47D RNA-seq and ChrRNA-seq data 2.24
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.24
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.24
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.23
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.22
Effect of CHKA knockdown on C4-2 cell transcriptome 2.22
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 2.21
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 2.21
Molecular Mechanisms of Endothelial Hyperpermeability 2.19
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.19
Regulation of hypoxia-inducible factor activity by ZMYND8 2.18
The bromodomain protein BRD4 regulates splicing during heat shock 2.13
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 2.1
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 2.1
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 2.08
Identification of a LIF-responsive replication-competent human β cell 2.07
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.06
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.05
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.05
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.04
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.04
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.03
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.03
Chromatin landscape of human visceral and subcutaneous adipocytes 2.0
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.99
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.99
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.99
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.99
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.98
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.98
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.96
RNA editing in nascent RNA affects pre-mRNA splicing 1.94
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.94
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.93
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.92
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.89
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.88
Discovering human diabetes-risk gene function with genetics and physiological assays 1.88
scRNASeq analysis of cycling cardiomyocytes 1.87
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.86
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.86
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.85
miR-93 Targets in Human Endothelial Cells 1.84
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 1.84
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.83
siRNA-mediated knockdown 1.82
Global transcriptome analysis of HAP1 cells 1.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.79
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.75
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.73
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.71
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.71
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.69
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.69
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.66
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.64
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.62
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.61
Single-cell analysis of adult human ovary using 10X genomics 1.59
RNA-sequencing in immortalized human mammary epithelial cells 1.58
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 1.58
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.58
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.49
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.47
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.46
iPSC-Derived Cholangiocytes 1.45
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.44
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.44
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.43
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.43
Gene expression signatures of innate lymphoid cells from human blood 1.42
High-resolution comparative analysis of great ape genomes 1.41
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.4
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.39
RNA-seq of naive and primed ES cells (NHSM) 1.38
RNA-Seq of PRMT1 overexpression ECA109 cells 1.36
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.35
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.32
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.28
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.28
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.27
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.27
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.27
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.26
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.24
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 1.22
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 1.22
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.22
Human ovarian granulosa cell transcriptome 1.21
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.19
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.19
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.19
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.17
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.17
Effect of FGF13 depletion on the H460 cell line 1.15
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.11
RNA-seq of MCF10A cells and CAF 1.11
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.07
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.07
RNA-Seq from human ILC transitional populations 1.07
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.06
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.06
Gene expression changes due to PARP knockdown in human cells 1.05
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.03
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.02
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.01
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.0
Epigenomic conservation of transposable element silencing 0.99
Epigenomic conservation of transposable element silencing [RNA-seq] 0.99
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 0.98
Systematic discovery of endogenous human ribonucleoprotein complexes 0.95
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.94
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 0.94
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 0.94
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.93
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.92
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.91
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.9
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.89
Proliferation-correlated expression 0.88
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.86
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.84
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 0.84
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.84
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.84
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.83
Human Treg IFNg/IL-10 subpopulations 0.83
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.78
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.78
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.77
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.77
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.71
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.7
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.67
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.67
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.66
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.66
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.66
Generation of KRAS signatures using immortalized isogenic lung cells. 0.65
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.63
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.63
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 0.63
MRTF activates TEAD-YAP target gene expression 0.62
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.62
Transcriptome-wide modulation of splicing by the exon junction complex 0.6
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.59
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.59
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.59
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.57
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.57
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.57
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.57
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.54
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.53
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.5
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.49
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.49
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.48
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.47
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.47
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.46
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.46
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.46
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.45
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.45
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.45
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.44
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.44
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.42
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.41
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.4
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.38
Identification of renal resident macrophages across species 0.38
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.37
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.36
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.34
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.33
RNA-seq data 0.33
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.33
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.33
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.31
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.31
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.3
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.27
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.26
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.25
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.24
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.22
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.18
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.18
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.18
Transcriptional landscape changes during human embryonic stem cell derivation 0.18
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.18
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.18
Human Treg IL-12 stimulation 0.15
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.13
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.12
Expression profiling of MCF-7 cells with treatment of TCDD 0.12
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.11
Effects of transcription on genome - nuclear lamina interactions 0.11
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.11
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.11
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.11
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.11
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 0.1
BMS-470539 on human synovial fibroblasts 0.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.09
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.08
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.08
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.07
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.07
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.07
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.05
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.05
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.05
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.05
RNA seq analysis of human Fetal and adult derived Enterospheres 0.04
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.02
Downregulation of LATS kinases alters p53 to promote cell migration 0.01
HEK293 TFAM Knockout Expression Study 0.01
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation